Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Drug Dosing: Infants and Children

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

Disorders of Erythrocytes

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

NT-proBNP and its correlation to left ventricular ejection fraction and heart failure - The DEMONSTRATE database.

Annals of clinical biochemistry·2025

Same author

Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome - a new kidney disorder defining selective glomerular hypofiltration syndromes - calls for expansion of the international KDIGO guidelines.

Scandinavian journal of clinical and laboratory investigation·2025

Same author

Patient medians for NT-proBNP from six Swedish counties 2011-2021.

Scandinavian journal of clinical and laboratory investigation·2025

Same author

Inter-laboratory variation for urine albumin among laboratories in a Swedish external quality assessment scheme 2005-2023.

Clinical biochemistry·2024

Same author

Demographic and disease-related factors impact bone turnover and vitamin D in children with hemato-oncological diseases.

JBMR plus·2024

Same author

Pediatric reference intervals for serum folate and cobalamin based on a European population without exposure to folic acid fortification.

Scandinavian journal of clinical and laboratory investigation·2024

Search research articles

Related Experiment Video

Updated: May 13, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Population-based pediatric reference intervals for hematology, iron and transferrin.

Mattias Aldrimer¹, Peter Ridefelt, Peo Rödöö

¹Department of Clinical Chemistry, County Hospital of Falun, Falun, Sweden.

Scandinavian Journal of Clinical and Laboratory Investigation

|March 2, 2013

Summary

This study establishes age- and gender-specific pediatric reference intervals for hematology and anemia analytes in healthy children. These new reference values aid clinicians in diagnosing conditions in pediatric populations.

More Related Videos

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

Related Experiment Videos

Last Updated: May 13, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

Area of Science:

Clinical Chemistry
Pediatric Hematology

Background:

Reference intervals are essential for clinical decision-making in differentiating healthy from diseased individuals.
Pediatric reference intervals for many blood analytes are often lacking or incomplete, hindering accurate diagnosis in children.

Purpose of the Study:

To establish comprehensive, age- and gender-specific pediatric reference intervals for key hematology and anemia analytes.
To provide clinicians with reliable data for the accurate assessment of children's health status.

Main Methods:

Blood samples were collected from 689 healthy children aged 6 months to 18 years.
Hematology and anemia analytes were measured using Siemens Advia 2120 and Abbott Architect ci8200 platforms.
Age- and gender-specific reference intervals were determined by calculating the 2.5th and 97.5th percentiles.

Main Results:

Defined pediatric reference intervals for hemoglobin, erythrocyte volume fraction (EVF), erythrocytes, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), reticulocytes, leukocytes, lymphocytes, monocytes, neutrophils, eosinophils, basophils, platelets, iron, transferrin, and transferrin saturation.
The generated data is primarily applicable to a Caucasian population but can be verified for local use.

Conclusions:

Established crucial reference intervals for pediatric hematology and anemia analytes.
These intervals support improved diagnostic accuracy in pediatric healthcare.
Laboratories can utilize this data after local verification.